Am J Hypertens

1. WANG L, Tian G, Liu X, Qu H, et al
   Association Between Plasma Aldosterone After Saline Infusion Test and Nocturnal Hypertension in Patients with Suspected Primary Aldosteronism.
   Am J Hypertens. 2026 Feb 5:hpag007. doi: 10.1093.
   

   >> Share

   
   
2. ZOGHBY ZM
   Commentary on "Current Landscape of Mobile Health Applications for Hypertension Management in the United States: A Scoping Application Review".
   Am J Hypertens. 2026 Feb 3:hpag004. doi: 10.1093.
   

   >> Share

   
   

   
   Angiology

3. SARIHAN A, Bekar L, Yetim M, Celik MC, et al
   Prognostic Value of Non-Dipping Nocturnal Heart Rate for Ventricular Arrhythmias in Isolated Hypertension.
   Angiology. 2026 Jan 31:33197261416011. doi: 10.1177/00033197261416011.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

4. MORIKAWA K, Arima Y, Nagakura T, Xu Y, et al
   Nonsteroidal mineralocorticoid receptor antagonist finerenone ameliorates cardiac hypertrophy with increasing glucocorticoid signaling sensitivity.
   Biochem Biophys Res Commun. 2026;802:153332.
   

   >> Share

   
   

   
   BMC Neurol

5. HAQ NU, Khan BA, Ali MZ, Sadbar S, et al
   Visual and headache outcomes following lumboperitoneal shunting in idiopathic intracranial hypertension: a prospective observational study.
   BMC Neurol. 2026 Feb 7. doi: 10.1186/s12883-026-04712.
   

   >> Share

   
   

   
   Clin Cardiol

6. AHMED S, Nadeem ZA, Nadeem A, Ashraf H, et al
   Mortality Due to Aortic Dissection in Adults With Primary Hypertension: A Nationwide Analysis Over Two Decades.
   Clin Cardiol. 2026;49:e70269.
   

   >> Share

   
   

   
   Clin Exp Hypertens

7. FARAHMAND M, Nazarpour S, Malmir H, Hosseinpour-Niazi S, et al
   Presenting non-insulin-based indices of insulin resistance relevant to pre-hypertension: A systematic review and meta-analysis.
   Clin Exp Hypertens. 2026;48:2625124.
   

   >> Share

   
   

   
   Eur Heart J

8. GHIO S, Badagliacca R, D'Alto M, Acquaro M, et al
   Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up.
   Eur Heart J. 2026 Feb 6:ehag023. doi: 10.1093.
   

   >> Share

   
   

   
   Eur J Pharmacol

9. HUANG BB, Yu X, Cai ZD, Wu JM, et al
   CAMK1D and PI3 in Low-density Neutrophils Are Associated with the Anti-hypertensive Effects of Valsartan.
   Eur J Pharmacol. 2026 Jan 31:178613. doi: 10.1016/j.ejphar.2026.178613.
   

   >> Share

   
   

   
   Hypertension

10. DE SILVA TM, Sabharwal R, Gerhold TD, Lynch C, et al
    Sex-Specific Blood Pressure and Brain Microvascular Traits in a Model of Low-Renin Hypertension.
    Hypertension. 2026 Feb 5. doi: 10.1161/HYPERTENSIONAHA.125.25795.
    

    >> Share

    
    
11. NARITA K, Bowling CB, Cannavale K, Fang C, et al
    Association Between Postprandial Hypotension Determined by Ambulatory Blood Pressure Monitoring and Falls Among Older Adults With Hypertension Who Are Taking Antihypertensive Medication: Results From the AMBROSIA Study.
    Hypertension. 2026 Feb 5. doi: 10.1161/HYPERTENSIONAHA.125.25518.
    

    >> Share

    
    
12. LI SS, Guo M, Zhao Y, Huang S, et al
    circMFN2 Regulates the IGF2BP3-PDK4 to Ameliorate Pulmonary Hypertension.
    Hypertension. 2026 Feb 5. doi: 10.1161/HYPERTENSIONAHA.125.25460.
    

    >> Share

    
    

    
    J Hum Hypertens

13. SUN C, Qu J, Liu T
    Predictors of blood pressure improvement in untreated hypertensive adults in china: a longitudinal analysis of urban-rural differences using CHARLS Data (2015-2020).
    J Hum Hypertens. 2026 Jan 30. doi: 10.1038/s41371-026-01117.
    

    >> Share

    
    

    
    J Hypertens

14. FRAGOULIS C, Maloberti A, Boulestreau R, De Backer T, et al
    Gaps between guidelines and practice in hypertensive urgencies and emergencies: data from a multinational European registry in ESH excellence centres.
    J Hypertens. 2026 Feb 5. doi: 10.1097/HJH.0000000000004231.
    

    >> Share

    
    
15. JIN L, Li Z, Li X, Wang X, et al
    Interaction between white coat effect and hypertension on arterial stiffness.
    J Hypertens. 2026 Feb 2. doi: 10.1097/HJH.0000000000004224.
    

    >> Share

    
    
16. LOPES J, Dalton-Alves F, Lopes S, Costa EC, et al
    The impact of exercise on resistant hypertension: what do we know in 2025?
    J Hypertens. 2026 Jan 23. doi: 10.1097/HJH.0000000000004242.
    

    >> Share

    
    
17. ELBAHLOUL MA, Ali AHG, Al-Shammari AS, Labeeb EE, et al
    Aldosterone synthase inhibitors for resistant or uncontrolled hypertension: a network meta-analysis of randomized clinical trials.
    J Hypertens. 2026 Feb 3. doi: 10.1097/HJH.0000000000004264.
    

    >> Share

    
    
18. SILEIKIENE V, Perone F, Badariene J, Sestokaite E, et al
    Prevalence and cardiometabolic risk of suspected and untreated hypertension in middle-aged Lithuanian men: insights from a cardiovascular disease prevention programme.
    J Hypertens. 2026 Jan 20. doi: 10.1097/HJH.0000000000004241.
    

    >> Share

    
    

    
    JAMA

19. HARDY ST, Jaeger BC, Emanuel E, Muntner P, et al
    Blood Pressure Above Goal Among US Adults With Hypertension.
    JAMA. 2026 Feb 2:e2525657. doi: 10.1001/jama.2025.25657.
    

    >> Share

    
    

    
    PLoS One

20. VIDZRO SE, Ansu-Mensah M, Dlamini S, Kuupiel D, et al
    Implementation of mobile health interventions in hypertension management and outcomes: A scoping review protocol.
    PLoS One. 2026;21:e0342224.
    

    >> Share

    
    
21. CHEN KL, Duemmel S, Christof M, Wang G, et al
    Mixed effects of complement in a chronic murine model of inflammatory erosive arthritis and pulmonary vascular disease.
    PLoS One. 2026;21:e0340677.
    

    >> Share

    
    
22. DUTTA P, Layton AT
    Unraveling the mechanistic links between blood pressure regulation and calcium-magnesium homeostasis: Insights into hypertension, hyperparathyroidism, and mineral disorders.
    PLoS One. 2026;21:e0341800.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share